🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a Phase III, randomized, double-blind, placebo-controlled, multice...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT00282347
RATIONALE: Giving chemotherapy, such as clofarabine, melphalan, and thiotep...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11-20
Trial ID
NCT00423514
A multicenter, randomized, study will be performed to evaluate the efficacy...
Status
Completed
Location
Henri Mondor Hospital
Start Date
2009-10
Trial ID
NCT01197040
Treatments Being Tested
This is a Phase III, randomized, double-blind, double-dummy, active-compara...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2015-05-26
Trial ID
NCT02383589
Treatments Being Tested
Dyskeratosis congenita is a disease that affects numerous parts of the body...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2012-07
Trial ID
NCT01659606
Treatments Being Tested
This study was designed to evaluate the renal function comparing Certican b...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-27
Trial ID
NCT01843348
The purpose of this study is to find out how well the current drug regimen ...
Status
Terminated
Location
Montefiore Medical Center
Start Date
2012-03
Trial ID
NCT01473732
Treatments Being Tested
Monoclonal antibodies, such as yttrium Y 90 ibritumomab tiuxetan, can block...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2004-06
Trial ID
NCT00119392
We hypothesize that mycophenolate mofetil(Cellcept)is safe and effective fo...
Status
Completed
Location
Oklahoma Medical Research Foundation
Start Date
2006-11
Trial ID
NCT00594932
Treatments Being Tested
This phase I trial studies the side effects and best dose of iodine I 131 m...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
1999-07-27
Trial ID
NCT00008177